Panimaya J. Miranda
Melbourne, VIC 3000, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Ion channel modulator DPI-201-106 significantly enhances antitumor activity of DNA damage response inhibitors in glioblastoma.
Journal: Neuro-oncology advances
Published: December 11, 2024
Current approaches in tissue engineering-based nanotherapeutics for osteosarcoma treatment.
Journal: Biomedical materials (Bristol, England)
Published: September 16, 2023
Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status.
Journal: Cancers
Published: July 12, 2022
ErbB4 in the brain: Focus on high grade glioma.
Journal: Frontiers in oncology
Published: July 01, 2022
miR-590-3p inhibits proliferation and promotes apoptosis by targeting activating transcription factor 3 in human breast cancer cells.
Journal: Biochimie
Published: May 23, 2018
The role of MDM2 and MDM4 in breast cancer development and prevention.
Journal: Journal of molecular cell biology
Published: December 23, 2016
MDM4 is a rational target for treating breast cancers with mutant p53.
Journal: The Journal of pathology
Published: August 19, 2016
Regulation of Mutant p53 Protein Expression.
Journal: Frontiers in oncology
Published: October 30, 2015
Runx2: Structure, function, and phosphorylation in osteoblast differentiation.
Journal: International journal of biological macromolecules
Published: January 21, 2015
A feedback expression of microRNA-590 and activating transcription factor-3 in human breast cancer cells.
Journal: International journal of biological macromolecules
Published: May 20, 2014
Regulation of breast cancer and bone metastasis by microRNAs.
Journal: Disease markers
Published: June 17, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026